列线图
医学
多发性骨髓瘤
肿瘤科
内科学
免疫系统
比例危险模型
免疫学
淋巴细胞
CD8型
生存分析
危险分层
免疫衰老
外周血淋巴细胞
曲线下面积
免疫病理学
逻辑回归
生物标志物
优势比
作者
Xianghong Zhao,Zhaoyun Liu,Gong Qin,Junzhu Wang,Hui Liu,Kai Ding,Jia Song,Rong Fu
摘要
Summary Immune dysregulation is involved in multiple myeloma (MM) pathogenesis and progression yet current staging systems do not incorporate indicators of immune status. We retrospectively included 260 newly diagnosed multiple myeloma (NDMM) patients with baseline data of peripheral blood (PB) lymphocyte subsets and cytokines from Tianjin Medical University General Hospital. Through majority voting across seven survival prediction algorithms and subsequent Cox analysis, cluster of differentiation (CD)3 + CD8 + T‐cell absolute count and interleukin (IL‐10) were identified as immune prognostic predictors to construct the immune risk score. A comprehensive prognostic nomogram was subsequently established by combining this score with high‐risk cytogenetic abnormalities, serum calcium and serum lactate dehydrogenase. Shapley additive explanation analysis ranked the immune risk score as the leading contributor to the final model. The nomogram achieved a cross‐validated 3‐year time‐dependent area under the curve for overall survival (OS) of 0.825. The model was further evaluated in a temporal validation cohort. In exploratory analyses within our cohort, the nomogram showed better prognostic performance than the established staging systems and further stratified outcomes among patients receiving anti‐CD38 antibody‐containing regimens. The model was deployed as an exploratory online calculator for convenience. These findings require independent external multicentre validation before implementation.
科研通智能强力驱动
Strongly Powered by AbleSci AI